Metabolic fates of L-tryptophan in Saccharomyces uvarum (Saccharomyces carlsbergensis). 1991

M Shin, and T Shinguu, and K Sano, and C Umezawa
School of Pharmacy, Kobe-Gakuin University, Japan.

The metabolism of L-tryptophan by Saccharomyces uvarum (carlsbergensis) was investigated by simultaneous measuring of fluxes through kynureninase, through transaminases and into protein using L-[methylene-14C] and L-[side chain-2,3-3H]tryptophan. In yeasts cultivated in synthetic medium (S medium), the flux into protein was predominant, closely followed by the flux leading to 2-3H liberation. The proportion of L-tryptophan metabolized via the latter flux increased over 10-fold (75% of total tryptophan metabolized) as the concentration of L-tryptophan was raised from 5 x 10(-5) to 5 x 10(-4) M. L-Tryptophan metabolized via the kynureninase flux was less than 5% of total tryptophan metabolized. In yeast extract-polypepton-glucose medium (YPG medium), more tryptophan was incorporated into protein than in the S medium. Contribution of the kynureninase flux remained very low. Tryptophan metabolism via each flux changed depending on the growth phase. 2-3H liberation was shown to be primarily due to tryptophol synthesis by high performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), indole-3-acetic acid and kynurenic acid also contributing to 2-3H liberation but to a much lesser extent. 2-3H liberation increased dose-dependently at tryptophan concentration higher than 10(-5)M, while the kynureninase flux reached its plateau at 10(-5)M. Formation of tryptophol and indole-3-acetic acid via indole-3-pyruvic acid and indole-3-acetaldehyde with indole aldehyde as a by-product was confirmed using exogenous tryptophan metabolites with indole rings.

UI MeSH Term Description Entries
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012440 Saccharomyces A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES. Saccharomyce
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan

Related Publications

M Shin, and T Shinguu, and K Sano, and C Umezawa
June 1991, Journal of nutritional science and vitaminology,
M Shin, and T Shinguu, and K Sano, and C Umezawa
May 1997, Canadian journal of microbiology,
M Shin, and T Shinguu, and K Sano, and C Umezawa
January 1982, Journal of nutritional science and vitaminology,
M Shin, and T Shinguu, and K Sano, and C Umezawa
January 1990, Folia microbiologica,
M Shin, and T Shinguu, and K Sano, and C Umezawa
May 1970, The Biochemical journal,
M Shin, and T Shinguu, and K Sano, and C Umezawa
March 2016, FEMS yeast research,
M Shin, and T Shinguu, and K Sano, and C Umezawa
December 1967, European journal of biochemistry,
M Shin, and T Shinguu, and K Sano, and C Umezawa
June 1983, Journal of bacteriology,
M Shin, and T Shinguu, and K Sano, and C Umezawa
February 1968, The Journal of biological chemistry,
M Shin, and T Shinguu, and K Sano, and C Umezawa
October 1972, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Copied contents to your clipboard!